Enhanced myocardial blood flow in ischemic cardiomyopathy by a slow-release synthetic prostacyclin agonist combined with coronary artery bypass grafting: The first human study in a Phase I/IIa clinical trial

BACKGROUND: YS-1402, which is a polymerized form of the synthetic prostacyclin agonist ONO-1301, has been proven in several preclinical studies to induce therapeutic effects for patients with ischemic cardiomyopathy (ICM). In this human study, we assessed the safety, tolerability, and efficacy of YS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Takuji, Yoshioka, Daisuke, Kawamura, Masashi, Matsuura, Ryohei, Kawamura, Ai, Misumi, Yusuke, Mikami, Tsubasa, Sawa, Yoshiki, Miyagawa, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905424/
https://www.ncbi.nlm.nih.gov/pubmed/36760570
http://dx.doi.org/10.3389/fcvm.2023.1047666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905424/
https://www.ncbi.nlm.nih.gov/pubmed/36760570
http://dx.doi.org/10.3389/fcvm.2023.1047666

Ejemplares similares